CACI International Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CACI International Inc. on June 26, 2007. The filing discloses significant changes to the Company's executive leadership and associated compensatory arrangements effective July 1, 2007.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on executive appointments and compensation adjustments.
Material Changes
The primary material change is the restructuring of the Company's top executive roles:
- Paul M. Cofoni: Appointed Chief Executive Officer and President, effective July 1, 2007. He previously served as President, U.S. Operations, of CACI-INC. FEDERAL.
- Dr. J.P. London: Stepped down as Chief Executive Officer and President. He remains Chairman of the Board and assumes the new full-time role of Executive Chairman, effective July 1, 2007.
Compensatory Arrangements and Management Commentary
Significant adjustments to base salary, incentive bonus targets, and equity grants were made in connection with the leadership transition:
| Executive | Role Change | Base Salary Change | Bonus Target Change | Equity Grant |
|---|---|---|---|---|
| Paul M. Cofoni | CEO & President | $510,000 to $675,000 | $1,013,000 to $1,325,000 | 300,000 SSARs (Exercise Price: $50.43) |
| Dr. J.P. London | Executive Chairman | $715,000 to $500,000 | $1,736,000 to $500,000 | Eligible for future awards (No specific grant noted) |
Both executives remain eligible for long-term incentive awards in the form of Stock Settled Appreciation Rights (SSARs), restricted stock, or other methods approved by the Compensation Committee.
Investor Verification Checklist
- Verify the effective date of the leadership transition (July 1, 2007).
- Confirm the specific terms of the 300,000 SSARs granted to Mr. Cofoni, including vesting schedules.
- Review the definitive Proxy Statement filed October 16, 2006, for full biographical details on Mr. Cofoni.
- Monitor future filings for any additional long-term incentive awards granted to Dr. London in his new capacity.